Genmab reported 168.38B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Almirall ALM:SM 2.64B 341.48M
Amarin AMRN:US 1.73B 715.38M
Amgen AMGN:US $ 140.05B 3.22B
Argen X Bv ARGX:BB 12.99B 1.05B
AstraZeneca AZN:LN 113.99B 18.86B
Bayer BAYN:GR 50.48B 2.53B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Exelixis EXEL:US $ 5.71B 1.36B
Fresenius Medical Care FME:GR 20.52B 2.15B
Galapagos GLPG:NA 3.83B 499.87M
Genmab GEN:DC 168.38B 31.59B
GlaxoSmithKline GSK:LN 71.42B 6.62B
GN Store Nord GN:DC 75.69B 4.64B
GRIFOLS GRF:SM 13.6B 337.76M
H. Lundbeck A/S LUN:DC 39.73B 3.43B
Hikma Pharmaceutical HIK:LN 5.66B 142.14M
Immunogen IMGN:US $ 1.32B 300.21M
Insmed INSM:US $ 3.22B 293.47M
Lonza Group LONN:SW 48.84B 6.48B
Merck MRK:GR 20.9B 2.08B
Novartis NOVN:VX 208.02B 8.76B
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sanofi SAN:FP 111.4B 5.33B
Seattle Genetics SGEN:US $ 28.65B 3.48B
UCB UCB:BB 17.15B 715.78M
William Demant Holding WDH:DC 84.77B 26.85B